Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;17(6):779-781.
doi: 10.2215/CJN.04930422.

Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis

Matthew J Oliver  1   2 , Peter G Blake  2   3
Affiliations
Editorial

Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis

Matthew J Oliver et al. Clin J Am Soc Nephrol. 2022 Jun.
No abstract available

Keywords: COVID-19; chronic hemodialysis; vaccination.

PubMed Disclaimer

Comment on

  • Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.
    Ashby DR, Caplin B, Corbett RW, Asgari E, Kumar N, Sarnowski A, Hull R, Makanjuola D, Cole N, Chen J, Nyberg S, McCafferty K, Zaman F, Cairns H, Sharpe C, Bramham K, Motallebzadeh R, Anwari KJ, Salama AD, Banerjee D; Pan-London COVID-19 Renal Audit Group. Ashby DR, et al. Clin J Am Soc Nephrol. 2022 Jun;17(6):843-850. doi: 10.2215/CJN.16621221. Clin J Am Soc Nephrol. 2022. PMID: 35649718 Free PMC article.

References

    1. Taji L, Thomas D, Oliver MJ, Ip J, Tang Y, Yeung A, Cooper R, House AA, McFarlane P, Blake PG: COVID-19 in patients undergoing long-term dialysis in Ontario. CMAJ 193: E278–E284, 2021 - PMC - PubMed
    1. Yau K, Abe KT, Naimark D, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Mullin SI, Shadowitz E, Gonzalez A, Sukovic T, Garnham-Takaoka J, de Launay KQ, Takaoka A, Straus SE, McGeer AJ, Chan CT, Colwill K, Gingras AC, Hladunewich MA: Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis. JAMA Netw Open 4: e2123622, 2021 - PMC - PubMed
    1. Ashby DR, Caplin B, Corbett RW, Asgari E, Kumar N, Sarnowski A, Hull R, Makanjuola D, Cole N, Chen J, Nyberg S, McCafferty K, Zaman F, Cairns H, Sharpe C, Bramham K, Motallebzadeh R, Anwari KJ, Salama AD, Banerjee D; the Pan-London COVID-19 Renal Audit Group : Severity of COVID-19 after vaccination among hemodialysis patients: An observational cohort study. Clin J Am Soc Nephrol 17: 843–850, 2022 - PMC - PubMed
    1. Oliver MJ, Thomas D, Balamchi S, Ip J, Naylor K, Dixon SN, McArthur E, Kwong J, Perl J, Atiquzzaman M, Singer J, Yeung A, Hladunewich M, Yau K, Garg AX, Leis JA, Levin A, Krajden M, Blake PG: Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes in the maintenance dialysis population in Ontario, Canada. J Am Soc Nephrol 33: 839–849, 2022 - PMC - PubMed
    1. Sibbel S, McKeon K, Luo J, Wendt K, Walker AG, Kelley T, Lazar R, Zywno ML, Connaire JJ, Tentori F, Young A, Brunelli SM: Real-world effectiveness and immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in patients on hemodialysis. J Am Soc Nephrol 33: 49–57, 2022 - PMC - PubMed

Substances